naltrexone has been researched along with Entrapment Neuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CM; Huang, EY; Tao, PL | 1 |
| Guilbaud, G; Kayser, V; Keïta, H | 1 |
| Catheline, G; Guilbaud, G; Kayser, V | 1 |
3 other study(ies) available for naltrexone and Entrapment Neuropathies
| Article | Year |
|---|---|
Supraspinal anti-allodynic and rewarding effects of endomorphins in rats.
Topics: Analgesics, Opioid; Animals; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nerve Compression Syndromes; Oligopeptides; Pain; Pain Management; Pain Measurement; Rats; Rats, Sprague-Dawley | 2004 |
Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy.
Topics: Analgesia; Analysis of Variance; Animals; Behavior, Animal; Blood-Brain Barrier; Disease Models, Animal; Drug Interactions; Hindlimb; Male; Naltrexone; Narcotic Antagonists; Nerve Compression Syndromes; Pain Threshold; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sciatic Nerve; Vocalization, Animal | 1995 |
Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats.
Topics: Analgesics; Animals; Benzeneacetamides; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Nerve Compression Syndromes; Pain Measurement; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sciatic Nerve; Somatostatin | 1998 |